Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

POINT Biopharma Global Inc (NASDAQ: PNT)

 
PNT Technical Analysis
5
As on 9th Jun 2023 PNT STOCK Price closed @ 10.24 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.43 & Strong Buy for SHORT-TERM with Stoploss of 6.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PNTSTOCK Price

Open 10.10 Change Price %
High 10.48 1 Day 0.13 1.29
Low 10.00 1 Week 0.83 8.82
Close 10.24 1 Month 2.59 33.86
Volume 703900 1 Year 5.21 103.58
52 Week High 10.86 | 52 Week Low 4.83
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
PNT
Daily Charts		 PNT
Intraday Charts		 Whats New @
Bazaartrend		 PNT
Free Analysis
 
PNT Important Levels Intraday
RESISTANCE11.16
RESISTANCE10.87
RESISTANCE10.68
RESISTANCE10.50
SUPPORT9.98
SUPPORT9.80
SUPPORT9.61
SUPPORT9.32
 
PNT Forecast May 2024
Share
4th UP Forecast14.04
3rd UP Forecast12.82
2nd UP Forecast12.07
1st UP Forecast11.31
1st DOWN Forecast9.17
2nd DOWN Forecast8.41
3rd DOWN Forecast7.66
4th DOWN Forecast6.44
 
PNT Weekly Forecast
4th UP Forecast12.57
3rd UP Forecast11.82
2nd UP Forecast11.36
1st UP Forecast10.90
1st DOWN Forecast9.58
2nd DOWN Forecast9.12
3rd DOWN Forecast8.66
4th DOWN Forecast7.91
 
PNT Forecast2024
4th UP Forecast23.5
3rd UP Forecast19.25
2nd UP Forecast16.62
1st UP Forecast13.99
1st DOWN Forecast6.49
2nd DOWN Forecast3.86
3rd DOWN Forecast1.23
4th DOWN Forecast-3.02
 
 
PNT Other Details
Segment EQ
Market Capital 712863424.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PNT Address
PNT
 
PNT Latest News
 
Your Comments and Response on POINT Biopharma Global Inc
 
PNT Business Profile
POINT Biopharma Global Inc., a late-stage clinical precision oncology company, focuses on the development and commercialization of radiopharmaceuticals for the treatment of cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer; and PNT-2004, a fibroblast activation protein-a targeted radioligand to treat solid tumors. POINT Biopharma Global Inc. is based in Indianapolis, Indiana. Address: 4850 West 78th Street, Indianapolis, IN, United States, 46268
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service